Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Blood|November 19, 2024
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemiaPeihua Lu, Xian Zhang, Junfang Yang, et al.
NPJ Precision Oncology|April 10, 2026
CD22-targeted immunotherapy for B-cell acute lymphoblastic leukemia progressing following CD19-targeted immunotherapyFengmei Song, Junfang Yang, Mingming Zhang, et al.
Chemical Communications (Cambridge, England)|February 13, 2025
Heptene end-capped Thiele hydrocarbons with tunable configuration and emission and on-surface transformation via annulationYilin Shu, Jianmin Huang, Junfang Yang, et al.
Frontiers in Oncology|July 8, 2022
Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T TherapyYu Zhao, Jianping Zhang, Junfang Yang, et al.
British Journal of Cancer|April 4, 2026
TCF3::HLF-positive B-ALL: integrated clinical and molecular characterization of 34 cases from a single-center cohortXue Chen, Xiaoli Ma, Lili Yuan, et al.
Blood Cancer Journal|July 7, 2022
Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical studyJunfang Yang, Jiaping He, Xian Zhang, et al.
Molecular Therapy Oncolytics|July 31, 2020
Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic LeukemiaXiangyu Zhao, Junfang Yang, Xian Zhang, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2021
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemiaXian Zhang, Junfang Yang, Jingjing Li, et al.
Nature Materials|August 7, 2024
A drug-mediated organic electrochemical transistor for robustly reusable biosensorsZiling Jiang, Dekai Ye, Lanyi Xiang, et al.
Immunotherapy|January 10, 2020
5 years of clinical DC-CIK/NK cells immunotherapy for acute myeloid leukemia - a summaryXian Zhang, Junfang Yang, Gailing Zhang, et al.
Pageof 6